Vectorious

Strategic investment

Worked with the team to give Vectorious’s evolving plans a coherent, tangible form at each stage of the strategic-investment process.

What happens to the heart between clinic visits? In heart failure, rising pressure can signal trouble before symptoms do.

A miniature implant makes those changes visible—connecting daily life with physician-guided care.

Vectorious, acquired by Edwards Lifesciences in 2025, develops V-LAP, an investigational platform that measures pressure inside the heart to support heart-failure care.

vectoriousmedtech.com